<?xml version='1.0' encoding='utf8'?>
<text id="AMALGUM_academic_epigenomic" title="Deconvolution of the Genomic and Epigenomic Interaction Landscape of Triple-Negative Breast Cancer" shortTitle="epigenomic" author="Jiande Wu, Tarun  Karthik Kumar Mamidi, Lu Zhang, Chindo Hicks" type="academic" dateCollected="2019-11-03" sourceURL="https://www.mdpi.com/2072-6694/11/11/1692/htm" speakerList="none" speakerCount="0">
<head>
<s type="frag">
1.	LS	1.
Introduction	NN	introduction
</s>
</head>
<p>
<s type="decl">
Triple-negative	JJ	Triple-negative
breast	NN	breast
cancer	NN	cancer
(	-LRB-	(
TNBC	NNP	TNBC
)	-RRB-	)
is	VBZ	be
a	DT	a
heterogeneous	JJ	heterogeneous
disease	NN	disease
,	,	,
characterized	VBN	characterize
by	IN	by
aggressive	JJ	aggressive
clinical	JJ	clinical
behavior	NN	behavior
,	,	,
poor	JJ	poor
prognosis	NN	prognosis
,	,	,
a	DT	a
significantly	RB	significantly
increased	VBN	increase
risk	NN	risk
of	IN	of
relapse	NN	relapse
,	,	,
and	CC	and
shorter	JJR	short
survival	NN	survival
rates	NNS	rate
than	IN	than
patients	NNS	patient
affected	VBN	affect
by	IN	by
other	JJ	other
molecular	JJ	molecular
subtypes	NNS	subtype
of	IN	of
breast	NN	breast
cancer	NN	cancer
.	.	.
</s>
<s type="decl">
TNBC	NNP	TNBC
is	VBZ	be
clinically	RB	clinically
defined	VBN	define
as	IN	as
tumors	NNS	tumor
that	WDT	that
lack	VBP	lack
expression	NN	expression
of	IN	of
the	DT	the
estrogen	NN	estrogen
receptor	NN	receptor
(	-LRB-	(
ER	NNP	ER
)	-RRB-	)
,	,	,
progesterone	NN	progesterone
receptor	NN	receptor
(	-LRB-	(
PR	NNP	PR
)	-RRB-	)
,	,	,
and	CC	and
HER2	NN	her2
amplification	NN	amplification
.	.	.
</s>
<s type="decl">
It	PRP	it
affects	VBZ	affect
primarily	RB	primarily
younger	JJR	young
premenopausal	JJ	premenopausal
women	NNS	woman
and	CC	and
tends	VBZ	tend
to	TO	to
have	VB	have
higher	JJR	high
incidences	NNS	incidence
in	IN	in
African	JJ	African
American	JJ	American
women	NNS	woman
,	,	,
although	IN	although
recent	JJ	recent
studies	NNS	study
reported	VBD	report
no	DT	no
differences	NNS	difference
in	IN	in
clinical	JJ	clinical
outcomes	NNS	outcome
between	IN	between
Caucasian	JJ	Caucasian
and	CC	and
African	JJ	African
American	JJ	American
women	NNS	woman
after	IN	after
adjusting	VBG	adjust
for	IN	for
socioeconomic	JJ	socioeconomic
factors	NNS	factor
.	.	.
</s>
<s type="decl">
Currently	RB	currently
,	,	,
there	EX	there
are	VBP	be
no	DT	no
effective	JJ	effective
targeted	VBN	target
therapies	NNS	therapy
.	.	.
</s>
<s type="decl">
Cytotoxic	JJ	Cytotoxic
chemotherapy	NN	chemotherapy
remains	VBZ	remain
the	DT	the
only	JJ	only
effective	JJ	effective
therapeutic	JJ	therapeutic
modality	NN	modality
for	IN	for
this	DT	this
aggressive	JJ	aggressive
and	CC	and
often	RB	often
lethal	JJ	lethal
type	NN	type
of	IN	of
breast	NN	breast
cancer	NN	cancer
.	.	.
</s>
<s type="decl">
Therefore	RB	therefore
,	,	,
there	EX	there
is	VBZ	be
an	DT	a
urgent	JJ	urgent
need	NN	need
for	IN	for
the	DT	the
discovery	NN	discovery
of	IN	of
molecular	JJ	molecular
markers	NNS	marker
and	CC	and
targets	NNS	target
for	IN	for
the	DT	the
development	NN	development
of	IN	of
novel	NN	novel
targeted	VBN	target
therapeutics	NNS	therapeutics
.	.	.
</s>
</p>
<p>
<s type="decl">
Our	PRP$	our
understanding	NN	understanding
of	IN	of
the	DT	the
molecular	JJ	molecular
basis	NN	basis
of	IN	of
TNBC	NN	TNBC
and	CC	and
development	NN	development
of	IN	of
effective	JJ	effective
targeted	VBN	target
therapies	NNS	therapy
has	VBZ	have
been	VBN	be
hampered	VBN	hamper
by	IN	by
the	DT	the
complexity	NN	complexity
and	CC	and
multifactorial	JJ	multifactorial
etiology	NN	etiology
of	IN	of
the	DT	the
disease	NN	disease
.	.	.
</s>
<s type="decl">
Genes	NNS	gene
play	VBP	play
a	DT	a
major	JJ	major
role	NN	role
in	IN	in
the	DT	the
pathogenesis	NN	pathogenesis
of	IN	of
TNBC	NNP	TNBC
.	.	.
</s>
<s type="decl">
The	DT	the
majority	NN	majority
of	IN	of
TNBC	NNP	TNBC
patients	NNS	patient
carry	VBP	carry
mutations	NNS	mutation
in	IN	in
the	DT	the
highly	RB	highly
penetrant	JJ	penetrant
cancer	NN	cancer
susceptibility	NN	susceptibility
genes	NNS	gene
BRCA1	NNP	BRCA1
and	CC	and
BRCA2	NNP	BRCA2
.	.	.
</s>
<s type="decl">
In	IN	in
unselected	JJ	unselected
TNBC	NNP	TNBC
cases	NNS	case
,	,	,
the	DT	the
prevalence	NN	prevalence
of	IN	of
pathogenic	JJ	pathogenic
germline	NN	germline
<hi rend="italic">
BRCA1	NNP	BRCA1
</hi>
and	CC	and
<hi rend="italic">
BRCA2	NNP	BRCA2
</hi>
mutations	NNS	mutation
is	VBZ	be
approximately	RB	approximately
twice	RB	twice
as	RB	as
high	JJ	high
as	IN	as
in	IN	in
breast	NN	breast
cancer	NN	cancer
overall	RB	overall
.	.	.
</s>
<s type="decl">
Apart	RB	apart
from	IN	from
<hi rend="italic">
BRCA1	NNP	BRCA1
</hi>
and	CC	and
<hi rend="italic">
BRCA2	NNP	BRCA2
</hi>
,	,	,
the	DT	the
rarely	RB	rarely
mutated	VBN	mutate
breast	NN	breast
cancer	NN	cancer
predisposition	NN	predisposition
genes	NNS	gene
<hi rend="italic">
PALB2	NNP	PALB2
</hi>
and	CC	and
<hi rend="italic">
FANCM	NNP	FANCM
</hi>
have	VBP	have
been	VBN	be
associated	VBN	associate
with	IN	with
TNBC	NNP	TNBC
.	.	.
</s>
<s type="decl">
Multigene	NNP	Multigene
panel	NN	panel
testing	NN	testing
has	VBZ	have
also	RB	also
identified	VBN	identify
genes	NNS	gene
with	IN	with
high	JJ	high
and	CC	and
moderate	JJ	moderate
penetrance	NN	penetrance
associated	VBN	associate
with	IN	with
an	DT	a
increased	VBN	increase
risk	NN	risk
of	IN	of
developing	VBG	develop
TNBC	NNP	TNBC
.	.	.
</s>
<s type="decl">
However	RB	however
,	,	,
although	IN	although
genes	NNS	gene
may	MD	may
play	VB	play
a	DT	a
strong	JJ	strong
role	NN	role
,	,	,
molecular	JJ	molecular
epidemiology	NN	epidemiology
studies	NNS	study
suggest	VBP	suggest
that	IN	that
TNBC	NNP	TNBC
risk	NN	risk
is	VBZ	be
largely	RB	largely
determined	VBN	determine
by	IN	by
interactions	NNS	interaction
between	IN	between
genes	NNS	gene
and	CC	and
environment	NN	environment
.	.	.
</s>
<s type="decl">
Increased	VBN	increase
attention	NN	attention
has	VBZ	have
focused	VBN	focus
on	IN	on
epigenetic	JJ	epigenetic
variation	NN	variation
such	JJ	such
as	IN	as
DNA	NN	DNA
methylation	NN	methylation
and	CC	and
TNBC	NNP	TNBC
because	IN	because
enduring	VBG	endure
epigenetic	JJ	epigenetic
landmarks	NNS	landmark
define	VBP	define
the	DT	the
tumor	NN	tumor
microenvironment	NN	microenvironment
.	.	.
</s>
<s type="sub">
Moreover	RB	moreover
,	,	,
because	IN	because
DNA	NN	DNA
methylation	NN	methylation
regulates	VBZ	regulate
gene	NN	gene
expression	NN	expression
,	,	,
aberrant	JJ	aberrant
methylated	VBN	methylate
genes	NNS	gene
could	MD	could
serve	VB	serve
as	IN	as
complementary	JJ	complementary
diagnostic	JJ	diagnostic
tools	NNS	tool
,	,	,
prognostic	JJ	prognostic
markers	NNS	marker
and	CC	and
predictors	NNS	predictor
of	IN	of
response	NN	response
to	IN	to
treatment	NN	treatment
.	.	.
</s>
<s type="decl">
Thus	RB	thus
,	,	,
a	DT	a
critical	JJ	critical
knowledge	NN	knowledge
gap	NN	gap
,	,	,
and	CC	and
an	DT	a
unmet	JJ	unmet
medical	JJ	medical
need	NN	need
,	,	,
is	VBZ	be
understanding	VBG	understand
the	DT	the
interplay	NN	interplay
between	IN	between
genetic	JJ	genetic
(	-LRB-	(
both	CC	both
germline	JJ	germline
and	CC	and
somatic	JJ	somatic
)	-RRB-	)
variation	NN	variation
and	CC	and
epigenomic	JJ	epigenomic
variation	NN	variation
in	IN	in
TNBC	NNP	TNBC
.	.	.
</s>
</p>
<p>
<s type="decl">
Advances	NNS	advance
in	IN	in
microarray	NN	microarray
technology	NN	technology
have	VBP	have
enabled	VBN	enable
molecular	JJ	molecular
classification	NN	classification
of	IN	of
subtypes	NNS	subtype
of	IN	of
TNBC	NNP	TNBC
.	.	.
</s>
<s type="decl">
At	IN	at
least	JJS	least
,	,	,
several	JJ	several
clinically	RB	clinically
validated	VBN	validate
prognostic	JJ	prognostic
assays	NNS	assay
including	VBG	include
the	DT	the
Prosigna	NNP	Prosigna
PAM50	NNP	PAM50
,	,	,
MammaPrint	NNP	MammaPrint
and	CC	and
Oncotype	NNP	Oncotype
DX	NNP	DX
,	,	,
have	VBP	have
been	VBN	be
developed	VBN	develop
using	VBG	use
transcription	NN	transcription
profiling	NN	profiling
.	.	.
</s>
<s type="decl">
However	RB	however
,	,	,
although	IN	although
these	DT	this
primary	JJ	primary
analyses	NNS	analysis
have	VBP	have
been	VBN	be
successful	JJ	successful
in	IN	in
identifying	VBG	identify
prognostic	JJ	prognostic
markers	NNS	marker
,	,	,
they	PRP	they
have	VBP	have
been	VBN	be
unsuccessful	JJ	unsuccessful
in	IN	in
establishing	VBG	establish
the	DT	the
causal	JJ	causal
association	NN	association
between	IN	between
gene	NN	gene
expression	NN	expression
and	CC	and
the	DT	the
disease	NN	disease
.	.	.
</s>
<s type="decl">
High-throughput	JJ	High-throughput
genotyping	NN	genotyping
using	VBG	use
genome-wide	JJ	genome-wide
association	NN	association
studies	NNS	study
(	-LRB-	(
GWAS	NNP	GWAS
)	-RRB-	)
has	VBZ	have
enabled	VBN	enable
discovery	NN	discovery
of	IN	of
genetic	JJ	genetic
variants	NNS	variant
associated	VBN	associate
with	IN	with
an	DT	a
increased	VBN	increase
risk	NN	risk
of	IN	of
developing	VBG	develop
TNBC	NNP	TNBC
.	.	.
</s>
<s type="decl">
The	DT	the
recent	JJ	recent
surge	NN	surge
of	IN	of
next	JJ	next
generation	NN	generation
sequencing	NN	sequencing
of	IN	of
tumor	NN	tumor
genomes	NNS	genome
by	IN	by
large	JJ	large
multicenter	NN	multicenter
projects	NNS	project
,	,	,
such	JJ	such
as	IN	as
The	DT	the
Cancer	NNP	Cancer
Genome	NNP	Genome
Atlas	NNP	Atlas
(	-LRB-	(
TCGA	NNP	TCGA
)	-RRB-	)
and	CC	and
the	DT	the
International	NNP	International
Cancer	NNP	Cancer
Genome	NNP	Genome
Consortium	NNP	Consortium
(	-LRB-	(
ICGC	NNP	ICGC
)	-RRB-	)
,	,	,
have	VBP	have
generated	VBN	generate
comprehensive	JJ	comprehensive
catalogues	NNS	catalogue
of	IN	of
somatic	JJ	somatic
mutations	NNS	mutation
associated	VBN	associate
with	IN	with
TNBC	NNP	TNBC
.	.	.
</s>
<s type="decl">
The	DT	the
clonal	JJ	clonal
and	CC	and
mutational	JJ	mutational
spectrum	NN	spectrum
of	IN	of
primary	JJ	primary
TNBCs	NNS	TNBC
have	VBP	have
also	RB	also
been	VBN	be
characterized	VBN	characterize
.	.	.
</s>
<s type="decl">
We	PRP	we
recently	RB	recently
reported	VBD	report
oncogenic	JJ	oncogenic
interactions	NNS	interaction
between	IN	between
genes	NNS	gene
containing	VBG	contain
germline	NN	germline
and	CC	and
somatic	JJ	somatic
mutations	NNS	mutation
in	IN	in
TNBC	NNP	TNBC
.	.	.
</s>
</p>
<p>
<s type="decl">
However	RB	however
,	,	,
to	IN	to
date	NN	date
,	,	,
information	NN	information
on	IN	on
germline	NN	germline
,	,	,
somatic	JJ	somatic
and	CC	and
gene	NN	gene
expression	NN	expression
variation	NN	variation
has	VBZ	have
not	RB	not
been	VBN	be
leveraged	VBN	leverage
and	CC	and
integrated	VBN	integrate
with	IN	with
DNA	NN	DNA
methylation	NN	methylation
data	NNS	datum
to	TO	to
map	VB	map
the	DT	the
interplay	NN	interplay
between	IN	between
genetic	JJ	genetic
and	CC	and
epigenetic	JJ	epigenetic
variation	NN	variation
in	IN	in
TNBC	NNP	TNBC
.	.	.
</s>
<s type="sub">
This	DT	this
limited	JJ	limited
progress	NN	progress
must	MD	must
be	VB	be
balanced	VBN	balance
against	IN	against
the	DT	the
recognition	NN	recognition
that	IN	that
genomic	JJ	genomic
and	CC	and
epigenomic	JJ	epigenomic
alterations	NNS	alteration
have	VBP	have
long	RB	long
been	VBN	be
considered	VBN	consider
as	IN	as
two	CD	2
separate	JJ	separate
molecular	JJ	molecular
mechanisms	NNS	mechanism
participating	VBG	participate
in	IN	in
TNBC	NNP	TNBC
pathogenesis	NN	pathogenesis
.	.	.
</s>
<s type="decl">
The	DT	the
objective	NN	objective
of	IN	of
this	DT	this
investigation	NN	investigation
is	VBZ	be
to	TO	to
deconvolute	VB	deconvolute
the	DT	the
genomic	JJ	genomic
and	CC	and
epigenomic	JJ	epigenomic
interaction	NN	interaction
landscape	NN	landscape
,	,	,
and	CC	and
to	TO	to
discover	VB	discover
and	CC	and
characterize	VB	characterize
the	DT	the
molecular	JJ	molecular
networks	NNS	network
and	CC	and
signaling	NN	signaling
pathways	NNS	pathway
perturbed	VBN	perturb
by	IN	by
these	DT	this
interactions	NNS	interaction
in	IN	in
TNBC	NNP	TNBC
.	.	.
</s>
<s type="decl">
Our	PRP$	our
working	VBG	work
hypothesis	NN	hypothesis
was	VBD	be
that	IN	that
TNBC	NNP	TNBC
originates	VBZ	originate
from	IN	from
a	DT	a
complex	JJ	complex
interplay	NN	interplay
between	IN	between
genomic	JJ	genomic
(	-LRB-	(
both	CC	both
germline	JJ	germline
and	CC	and
somatic	JJ	somatic
)	-RRB-	)
variation	NN	variation
and	CC	and
epigenomic	JJ	epigenomic
variations	NNS	variation
.	.	.
</s>
<s type="decl">
We	PRP	we
further	RBR	far
hypothesized	VBD	hypothesize
that	IN	that
these	DT	this
complex	JJ	complex
arrays	NNS	array
of	IN	of
interacting	VBG	interact
genomic	JJ	genomic
and	CC	and
epigenomic	JJ	epigenomic
factors	NNS	factor
affect	VBP	affect
entire	JJ	entire
molecular	JJ	molecular
networks	NNS	network
and	CC	and
signaling	NN	signaling
pathways	NNS	pathway
which	WDT	which
,	,	,
in	IN	in
turn	NN	turn
,	,	,
drive	VBP	drive
TNBC	NNP	TNBC
.	.	.
</s>
<s type="decl">
We	PRP	we
addressed	VBD	address
these	DT	this
hypotheses	NNS	hypothesis
by	IN	by
integrating	VBG	integrate
information	NN	information
on	IN	on
germline	NN	germline
variation	NN	variation
from	IN	from
GWAS	NNP	GWAS
with	IN	with
information	NN	information
on	IN	on
somatic	JJ	somatic
and	CC	and
epigenomic	JJ	epigenomic
variation	NN	variation
from	IN	from
TCGA	NNP	TCGA
using	VBG	use
gene	NN	gene
expression	NN	expression
as	IN	as
the	DT	the
intermediated	NN	intermediate
phenotype	NN	phenotype
.	.	.
</s>
</p>
</text>